Duke University School of Medicine Milestones

  • Duke University School of Medicine Established

    As part of his endowment, James B. Duke makes an additional bequest to establish the Duke School of Medicine, Duke School of Nursing, and Duke Hospital, with the goal of improving health care in the Carolinas and nationwide. In 1924, James B. Duke established The Duke Endowment and directs that part of his $40-million gift be used to transform Durham's Trinity College into Duke University.
  • Wilburt Davison Selected as Dean of Duke University School of Medicine

    Wilburt Davison Selected as Dean of Duke University School of Medicine
    Wilburt Davison selected first dean of the Duke University School of Medicine and Hospital. Photo: Duke University Medical Center Archives
  • Construction begins on the Medical School and Duke Hospital.

  • Medical school classes begin

  • Duke Hospital opens

  • The School of Nursing opens

  • The Private Diagnostic Clinic (PDC) is organized

  • Ultraviolet Lamps First Used in ORs

    Ultraviolet Lamps First Used in ORs
    Duke surgeon J. Deryl Hart, MD, introduces ultraviolet lamps into operating rooms to kill airborne germs that cause post-operative staph infections, dramatically reducing the number of infections and related deaths. Photo: Duke University Medical Center Archives
  • Leader in Vaccine Development

    Joseph Beard develops a vaccine against equine encephalomyelitis.
  • First Brain Tumor Program in Nation

    Barnes Woodall establishes the nation's first brain tumor program.
  • Frederick Bernheim nominated for Nobel Prize

    For his studies of the metabolism of the tubercle bacillus, which eventually led to effective medications, pharmacologist Frederick Bernheim is nominated for the Nobel Prize.
  • Period: to

    Dietery Breakthrough

    Continuing through the 1940s and 1950s, Dr. Walter Kempner's research, using a rice-based diet and daily laboratory testing, demonstrates that degenerative processes attacking the kidney, heart, brain and retina can be arrested by dietary changes. These dramatic findings draw patients to Duke from across the nation.
  • Neuropathology Lab and Brain Tumor Clinic Established

    Guy Odom and Barnes Woodhall establish a neuropathology laboratory and brain tumor clinic.
  • Bell Research Building Opens

    Named after trustee William Bell, a new research building is opened. It was the first building of the medical center that wasn't connected with the main buildings.
  • Student Curriculum on Cancer Care Developed

    Duke launches a medical student program focused on the treatment of patients with cancer.
  • Medicine Bottles Given Childproof Safety Caps

    Medicine Bottles Given Childproof Safety Caps
    Duke pediatrician, Jay Arena, MD, leads the push for drug companies to develop the childproof safety cap for medicine bottles. Photo: Duke University Medical Center Archives
  • North Carolina Cerebral Palsy Hospital opens

    North Carolina Cerebral Palsy Hospital opens, established with federal funds on property donated by Duke University. It is later renamed Lenox Baker Hospital.
  • Leukemia Breakthrough

    Joseph Beard identifies links virus to leukemia in chickens, leading to first report of viral association with human leukemia.
  • Duke Poison Control Center Established

    Duke Poison Control Center Established
    Jay Arena establishes the Duke Poison Control Center. Photo Credit: Duke University Medical Center Archives
  • Duke Center for Aging Established

    Psychiatrist Ewald W. Busse establishes the Duke University Center for Aging, the first research center of its kind in the nation. Now the oldest continuously running aging center in the United States, the Duke Center for Aging has pioneered long-term studies of health problems among the elderly.
  • Southeastern Cancer Chemotherapy Cooperative Study Group Established

    R. Wayne Rundles leads the creation of the Southeastern Cancer Chemotherapy Cooperative Study Group and chairs the group for 10 years.
  • A First in Cardiac Surgery

    Duke becomes the first to use systemic hypothermia during cardiac surgery. This technique of cooling patients to minimize tissue damage during lengthy surgical procedures is now standard practice worldwide.
  • Duke surgeons become first to use systemic hypothermia during cardiac surgery.

    Duke becomes the first to use systemic hypothermia during cardiac surgery. This technique of cooling patients to minimize tissue damage during lengthy surgical procedures is now standard practice worldwide.
  • Frank Engle establishes the (Watson) Rankin Clinical Research Unit.

  • Period: to

    Barnes Woodall, MD Serves as Dean of School of Medicine

    Barnes Woodhall, MD, serves at dean of the medical school 1960-1964.
  • Duke Hospital Launches Clinical Research Program.

    Duke Hospital Launches Clinical Research Program.
    In a February 1961 edition of Intercom, Duke Hospital's internal newspaper: "Dr. Barnes Woodhall, Duke Medical School dean, tells us that the purpose of clinical research is 'the careful study of what takes place in various disease states' with 'precise evaluation of the effectiveness of new drugs and treatment methods."" Photo Credit: Duke University Medical Center Archives
  • Period: to

    Gerontology and Clinical Research Buildings Open

  • The hyperbaric chamber opens

  • First African-American Student

    W. Delano Meriwether is the first African-American student admitted to the School of Medicine.
  • Barnes Woodhall Named Vice Provost

    Barnes Woodhall becomes vice provost of Duke University.
  • Wolfgang Karl (Bill) Joklik is the first to describe the mechanism of action of interferon.

    Wolfgang Karl (Bill) Joklik is the first to describe the mechanism of action of interferon.
  • Period: to

    William Anlyan, MD, Serves as Chancellor of Medical Center and Dean of School of Medicine

    William G. Anlyan is dean of Duke University School of Medicine and chancellor of Duke University Medical Center.
  • First Kidney Transplant

    Duke performs first kidney transplant.
  • Physician Assistant Profession Founded at Duke

    Physician Assistant Profession Founded at Duke
    Eugene A. Stead, Jr., MD, establishes the nation's first Physician Assistant Program. Four former Navy corpsmen were recruited to comprise the first class of Duke PA students. Three of these students — Kenneth F. Ferrell, Victor H. Germino and Richard J. Scheele — completed the program in 1967. Photo Credit: Duke University Medical Center Archives
  • Databank for Cardiovascular Disease Organized

    Databank for Cardiovascular Disease Organized
    Eugene A. Stead, Jr., MD (pictured), organizes the Duke Databank for Cardiovascular Disease
  • Treatment for Gout Discovered

    James Wyngaarden lead team identifying allopurinol as a treatment for gout.
  • The Duke Medical Scientist (MD/PhD) Training Program is founded.

  • New Duke Hospital entrance, the Woodhall Building, opens.

  • First Consultive Radio Program

    Duke becomes the first medical center in the world to offer a consultative radio program to isolated doctors in other countries.
  • Evelyn Morgan becomes Duke’s first oncology clinical nurse specialist.

  • Enzyme Superoxide Dismutase Discovered

    Irwin Fridovich, PhD, and graduate student Joe McCord discover the enzyme superoxide dismutase, which protects all living things against the toxicity of oxygen.
  • Robert Lefkowitz describes the adrenaline receptor.

  • 1968 The Nanaline Duke Research Building opens.

  • William Shingleton is appointed to the National Cancer Advisory Committee.

  • Leukemia Breakthrough

    John Laszlo, C.E. Buckley III and Bernard Amos demonstrate that lymphocytic antibodies can decrease leukemic counts and lymph node size.
  • Community Hematology-Oncology Practice Opens

    Evelyn Coonrad, one of the first Duke-trained hematologist-oncologists, opens one of the first community hematology-oncology practices.
  • Hyperbaric Chamber Assess 1,000-Foot Deep-Sea Dive

    Duke uses hyperbaric chamber to assess ability to function and work at pressures equal to a 1,000-foot deep-sea dive.
  • Comprehensive Cancer Center Established

    The Duke Comprehensive Cancer Center becomes one of the nation’s first cancer centers to be established with the passage of the National Cancer Act. It is designated a "comprehensive" cancer center by the National Cancer Institute in 1973.
  • Pathology Assistant Program Established

    Thomas Kinney establishes the first Pathology Assistant Program.
  • Federal Law on Child Safety Caps Passed

    Child safety cap requirements championed by Jay Arena enacted as federal law.
  • Animal and Laboratory Isolation Facility Established

    Duke establishes the Animal and Laboratory Isolation Facility, to allow scientists to work with bacteria, viruses, and chemicals in a low risk environment. It is the first facility of its kind in the Southeast.
  • NIH Names Duke 1 of 8 Comprehensive Cancer Centers

    Duke named one of eight Comprehensive Cancer Centers by the National Cancer Institute.
  • Duke Eye Center Opens

    Duke Eye Center Opens
    On November 8, 1973, the Duke Eye Center (now called the Wadsworth Eye Center) was opened and dedicated. The $3.7 million project was the result of more than eight years of planning. Prior to its construction, patients with serious or unusual eye diseases often had to be referred to eye centers in distant places like New York, Baltimore, or Miami. Photo Credit: Duke University Medical Center Archives
  • Period: to

    New Medical and Research Buildings Open

    The Eye Center, Sands Research, Jones Research, Seeley G. Mudd, Morris Cancer Research Buildings and the new Duke Hospital open.
  • Cancer Citizens Advisory Council Established

    The Citizens Advisory Council, created within the Comprehensive Cancer Center (DCCC), to focus on education, advocacy, and support for people with cancer.
  • Discovery Related to Mastectomy and Breast Cancer

    Nicholas Georgiade, Gregory Georgiade, Kenneth McCarty Jr., B.J. Ferguson and Hilliard Seigler, report data showing no alteration in patient survival for immediate reconstruction done at the time of mastectomy.
  • Ribbon Diagram Published

    Ribbon Diagram Published
    Duke biophysicist Jane Richardson’s ribbon diagram, a method of representing the 3D structure of proteins, is first published.
  • "Bubble Boy Disease" Cured

    "Bubble Boy Disease" Cured
    Pediatric immunologist Rebecca Buckley, MD, uses bone marrow transplantation to cure severe combined immunodeficiency, also known as “bubble boy disease.” Photo Credit: Duke Health
  • Department Chair Named Director of NIH

    Department Chair Named Director of NIH
    James Wyngaarden, MD, Chair of the Department of Medicine, is named director of the National Institutes of Health. Photo Credit: Duke University Medical Center Archives
  • G-Protein Receptor Breakthrough

    Robert J. Lefkowitz and Brian K. Kobilka isolate and sequence the g-protein receptor.
  • HIV Research Breakthrough

    HIV Research Breakthrough
    Barton Haynes, MD, contributes to the identification of HTLV-III, now known as HIV. Photo Credit: Duke University School of Medicine
  • HIV Antiretroviral Therapy Discovery Made

    HIV Antiretroviral Therapy Discovery Made
    Kent Weinhold, PhD, identifies the in-vitro activity of AZT against HIV. Photo Credit: Duke University School of Medicine
  • First Clinical Trial for AIDS Drug

    First Clinical Trial for AIDS Drug
    Duke becomes one of two hospitals to conduct the first human clinical trials of AZT, the first drug to substantially improve quality of life for AIDS patients. David Durack conducts the Duke clinical trials.
  • HIV Prevention in Children Initiated

    HIV Prevention in Children Initiated
    Catherine Wilfert, MD, initiates antiretroviral therapy at delivery to prevent HIV transmission to children. Photo Credit: Duke University School of Medicine
  • Cancer Patient Support Program Founded

    Saul and Rachel Schanberg create the Duke Cancer Patient Support Program in memory of their daughter, Linda Schanberg Clark.
    http://dukecancerinstitute.org/duke-cancer-patient-support-program
  • Treatment of HIV-Infected Infants and Children Begins

    Treatment of HIV-Infected Infants and Children Begins
    Catherine Wilfert, MD, initiates treatment of HIV-infected infants and children with AZT. Photo Credit: Duke University School of Medicine
  • HIV Discoveries Continue

    HIV Discoveries Continue
    Dani Bolognesi, PhD, and team identify the V3 loop of HIV gp120 as the principal neutralizing domain. Photo Credit: Duke University Medical Center Archives
  • Breakthrough in Charcot-Marie-Tooth Disease

    Jeffery Vance, MD, PhD, and others localize the first of three loci associated with Charcot-Marie-Tooth disease.
  • Koo Foundation Sun Yat-Sen Cancer Center in Taiwan Established

    Koo Foundation Sun Yat-Sen Cancer Center in Taiwan Established
    Andrew T. Huang, MD, helps establish Koo Foundation Sun Yat-Sen Cancer Center in Taiwan. https://www.medicaltravel.org.tw/Hospital-Content.aspx?l=2&id=101 Photo Credit: Duke University School of Medicine
  • Period: to

    Ralph Snyderman, MD, Serves as Chancellor for Health Affairs and Dean of School of Medicine

    Ralph Snyderman, MD, served as Chancellor for Health Affairs and Dean of the School of Medicine at Duke University from 1989 to July 2004. During this time, he oversaw the development of the Duke University Health System and served as its first president and CEO. Photo Credit: Duke University Medical Center Archives
  • Alzheimer's Disease Breakthrough

    Duke researchers discover a gene that increases people’s risk of developing the most common form of Alzheimer’s disease, showing for the first time that it can be inherited.
  • Bryan Research Building Opens

  • Duke Pediatric Blood and Marrow Transplant Program Established

    Duke Pediatric Blood and Marrow Transplant Program Established
    Joanne Kurtzberg, MD, establishes the Duke Pediatric Blood and Marrow Transplant Program. Photo Credit: Duke Health
  • Breakthrough in Treatment for Thoracic Cancers

    Breakthrough in Treatment for Thoracic Cancers
    Jeffrey Crawford, MD, and colleagues lead the development of an innovative, multidisciplinary treatment for thoracic cancers and FDA approval of G-CSF for the prevention of chemotherapy-induced neutropenia. Photo Credit: Duke University School of Medicine
  • Outpatient Bone-Marrow Transplant Program Established

    Duke Comprehensive Cancer Center develops an outpatient bone-marrow transplantation program.
  • Center for Living Campus Opens

    Center for Living Campus Opens
    Nestled in the woods of Duke Forest, the Center for Living Campus at Duke University is the home of a host of health and wellness programs and clinics that provide innovative, personalized care. https://www.dukehealth.org/locations/duke-center-living-campus Photo Credit: Duke Health
  • First Lung Transpalant and First Heart-Lung Transplant

    Duke performs its first lung transplant and its first heart/lung transplant.
  • Standard Screening for Newborns Established

    Duke geneticists invent a three-minute test to screen newborns for over 30 metabolic diseases at once. Though devastating if undetected, the diseases can be controlled once identified. The test is now used throughout the country.
  • First Outpatient Bone Marrow Transplantation Program Established

    Duke Comprehensive Cancer Center (now Duke Cancer Institute) develops the nation’s first outpatient bone marrow transplantation program.
  • World's First Umbilical Cord Blood Transplant

    World's First Umbilical Cord Blood Transplant
    Joanne Kurtzberg, MD, performs the world’s first umbilical cord blood transplant at Duke, opening the door for lifesaving transplants between unmatched donors and recipients.
  • Breakthrough in Alzheimer's Disease Research

    Breakthrough in Alzheimer's Disease Research
    Allen Roses, MD, and others identify apolipoprotein E (apoE) as a susceptibility gene for Alzheimer’s disease. Photo Credit: Duke University School of Medicine
  • Duke Enrolls Final Patient in GUSTO-I

    Duke enrolls the final patient in GUSTO-I, leads to the Duke Clinical Research Institute (DCRI).
  • DiGeorge Syndrome Cured

    DiGeorge Syndrome Cured
    Pediatric immunologist Mary Louise Markert, MD, PhD, uses thymus transplantation to cure once-fatal complete DiGeorge Syndrome. Photo Credit: Duke University School of Medicine
  • Breast Cancer and Ovarian Cancer Gene Discovered

    Breast Cancer and Ovarian Cancer Gene Discovered
    Duke scientists help to discover BRCA1, the gene responsible for many inherited forms of breast and ovarian cancers. Photo Credit: Wikipedia, https://upload.wikimedia.org/wikipedia/commons/e/e1/Protein_BRCA1_PDB_1jm7.png
  • Period of New Construction at Duke University Medical Center

    The medical center embarks on the busiest period of new construction in decades, including the Levine Science Research Center, Medical Sciences Research Building, a complete renovation of Duke Clinic, additions to the Morris Building for cancer care and research, a new Children's Health Center, a new ambulatory care building, and new parking garages.
  • MRI Reveals First Images of Human Lung

    Duke and Princeton University scientists generate the first images of the human lung using magnetic resonance imaging (MRI). The new technique could greatly aid diagnosis and treatment of lung disorders such as emphysema and asthma.
  • BRCA1 and BRCA2 Genes Linked to Breast and Ovarian Cancers

    Duke scientists link the BRCA1 and BRCA2 genes to breast and ovarian cancers.
  • Anti-HIV Compound Discovered

    Tom Matthews and team discover anti-HIV compound, T-20.
  • Cord Blood Transplant in Adult Leukemic Patient

    Duke becomes one of the first groups to transplant an adult leukemic patient with cord blood after total body irradiation, cytoxan chemotherapy, and antithymocyte globulin.
  • Carolinas Cord Blood Bank Established

    Carolinas Cord Blood Bank Established
    Joanne Kurtzberg establishes the Carolinas Cord Blood Bank, a public cord blood bank at Duke. https://sites.duke.edu/ccbb/
  • Alzheimer's Marker Tracked and Identified

    Duke researchers are the first to use magnetic resonance spectroscopy to track levels of n-acetylaspartate (N-AA) as a marker for Alzheimer’s disease, proving that such a marker exists and that it can be detected.
  • MHS in Clinical Research Degree Established

    The NIH partners with Duke to offer a joint master of health sciences degree in clinical research.
  • DUHS Partners with Durham and Raleigh Regional Hospitals

    Duke University Health System partners with Durham Regional Hospital, Raleigh Community Hospital, and other regional health care providers.
  • Ralph Snyderman, MD, Named First President of DUHS

    Ralph Snyderman, MD, Named First President of DUHS
    Ralph Snyderman, MD, is named the first president of Duke University Health System.
  • Duke North Pavilion Ambulatory Surgery Center Opens

    Duke North Pavilion Ambulatory Surgery Center Opens
    Duke North Pavilion Ambulatory Surgery Center surgery center opens. Photo Credit: Duke Health
  • Duke Clinics Open

    Duke Clinics Open
    The original Duke Hospital (Duke South) reopens as Duke Clinics. Photo Credit: Duke Health
  • Advances in Stem Cell Transplant Research

    Rebecca Buckley and others publish hematopoietic stem cell transplantation for the treatment of severe combined immunodeficiency.
  • Period: to

    Edward W. Holmes, MD, Serves as Dean of the School of Medicine

    Edward W. Holmes, MD, is the fifth dean of Duke University School of Medicine. The position of dean for the Duke School of Medicine was first created in 1999 when the need was recognized to split off
    this responsibility from the chancellor for health affairs.
  • Duke Institute for Genome Sciences and Policy is founded.

  • McGovern-Davison Children’s Health Center Opens

    McGovern-Davison Children’s Health Center Opens
    The McGovern-Davison Children’s Health Center opens, bringing all of Duke’s pediatric specialties under one roof. The $32.5-million facility is completely paid for through philanthropy.
  • Duke Center for Cardiovascular Magnetic Resonance Imaging

  • Breakthrough in Paralysis Research

    Breakthrough in Paralysis Research
    Miguel Nicolelis, MD, PhD, develops a system that allows monkeys to control robot arms via brain signals, an important step to enable paralyzed people to control "neuroprosthetic" limbs.
  • Period: to

    R. Sanders Williams, MD, Serves as Dean of the School of Medicine

    R. Sanders Williams, MD, serves as Dean of the School of Medicine.
  • Genome Sciences Research Building I

    Genome Sciences Research Building I opens on LaSalle Road.
  • Advances in Alzheimer's Disease Drug Research

    Duke researchers demonstrate for the first time that magnetic resonance technology could be used to observe the effects of a medication on brain structures, an important first step toward improving drug research for treating Alzheimer’s disease.
  • Southeast Regional Center of Excellence for Emerging Infections and Biodefense (SERCEB) Founded

     Southeast Regional Center of Excellence for Emerging Infections and Biodefense (SERCEB) Founded
    Bart Haynes establishes the Southeast Regional Center of Excellence for Emerging Infections and Biodefense (SERCEB), to develop vaccines, drugs, and diagnostic tests against emerging infections.
  • Duke-NUS Medical School Founded

    Duke-NUS Medical School Founded
    Duke University and National University of Singapore (NUS) sign a Memorandum of Understanding to establish Singapore’s first graduate medical school. https://www.duke-nus.edu.sg/about/about-duke-nus/the-duke-nus-story/milestones Photo Credit: Duke-NUS
  • Duke Raleigh Hospital Established

    Duke Raleigh Hospital Established
    Raleigh Community Hospital changes its name to Duke Raleigh Hospital. Photo Credit: Duke Health
  • Duke Leads FDA-Approved Drug Studies

    The U.S. Food and Drug Administration approves the drug bevacizumab (Avastin®) for colon cancer, based on findings from a Duke lead, multicenter study. A subsequent Duke lead study lead to FDA approval of Avastin® for glioblastoma in 2009.
  • CIEMAS Expands Collaboration Between School of Medicine and Pratt School of Engineering

    The Center for Interdisciplinary Engineering, Medicine, and Applied Sciences (CIEMAS) opens, expanding the collaboration between the Pratt School of Engineering and the School of Medicine.
  • Period: to

    Victor J. Dzau, MD, Serves as Chancellor for Health Affairs and CEO of DUHS

    Victor J. Dzau, MD, served as Chancellor for Health Affairs and CEO of Duke University Health System from 2004 to 2014.
  • Discovery of Gene That Causes Blindness in Elderly

    Researchers at Duke and Vanderbilt universities discover the first major gene known to determine an individual’s risk for developing age-related macular degeneration, the leading cause of visual impairment and legal blindness in the elderly.
  • Eye Research Institute Opens

    Albert Eye Research Institute (AERI) opens.
  • Macular Degeneration Study

    Eric Postel and Margaret Pericak-Vance lead a study finding that complement factor H (CFH) is associated with macular degeneration.
  • HIV/AIDS Vaccine Development Center

    Center for HIV/AIDS Vaccine Immunology (CHAVI) dedicated to developing an HIV vaccine.
  • Preston Robert Tisch Brain Tumor Center Established

  • Center for Cancer Survivorship Founded

    The Duke Center for Cancer Survivorship is created. The program provides services designed to specifically meet the needs of survivors and conducts research related to cancer survivorship.
  • Treatment for Pompe Disease Approved by FDA

    The FDA approves Myozyme, the first lifesaving treatment for children with Pompe disease. The treatment was discovered and developed at Duke.
  • Duke Global Health Institute Founded

    Duke Global Health Institute Founded
    Formed in 2006 as part of Duke University’s commitment to spark innovation in global health research and education, the institute brings together knowledge and resources from across the university to address the most important global health issues of our time.
  • MURDOCK Study Funded

    MURDOCK Study Funded
    David H. Murdock funds the MURDOCK study in Kannapolis, NC. The MURDOCK Study, or the Measurement to Understand the Reclassification of Disease of Cabarrus/Kannapolis, is Duke University’s longitudinal health study working to reclassify health and disease through advanced scientific technologies, expertise from Duke researchers, and close collaboration with a strong network of local and regional community partners.
  • First Human Genome Map of Imprinted Genes Created

    First Human Genome Map of Imprinted Genes Created
    Alexander Hartemink, PhD, and others create the first human genome map of imprinted genes.
  • FDA-Approved Breast Cancer Treatment

    Duke researchers' work in the development and testing of lapatinib (Tykerb®) for breast cancer patients leads to FDA approval.
  • Period: to

    Nancy Andrews, MD, PhD, Serves as Dean of School of Medicine

    Nancy Andrews, MD, PhD, is the first woman named dean of the Duke University School of Medicine. She serves in the role from 2007 to 2017.
  • Breakthrough in Brain-Machine Interfaces (BMI)

    Breakthrough in Brain-Machine Interfaces (BMI)
    Miguel Nicolelis, MD, PhD, and the Japan Science and Technology Agency use the brain activity of a monkey to control the real-time walking patterns of a robot halfway around the world.
  • Duke Cell and Translational Therapy Program Established

    Julian Robertson funds the establishment of the Duke Cell and Translational Therapy Program
  • Duke Cancer Institute Founded

    The Duke Cancer Institute (DCI) is created to promote collaborations between individuals involved in cancer care, research, and education. Christopher Willett, MD, and Anthony Means, PhD, are named interim co-directors.
  • Brain Tumors Gene Mutations Discovered

    Brain Tumors Gene Mutations Discovered
    Hai Yan, MD, PhD, and a team of scientists from Duke and Johns Hopkins universities identify mutations in a gene that make cells immortal and appear to play a pivotal role in three of the most common types of brain tumors, as well as cancers of the liver, tongue and urinary tract. Photo Credit: Duke University School of Medicine
  • Primary Care Leadership Track Established in School of Medicine

    Duke Primary Care Leadership Track (PCLT) established is to create change agents for the health care system through primary care. The 4-year program offers leadership training, a longitudinal-integrated 2nd year clerkship, which includes following pregnant mothers and delivering their babies, time for service with a community health care agency, and 3rd year research in community-engaged population health.
  • Identification of Gene Mutations Related to Brain Tumors

    Identification of Gene Mutations Related to Brain Tumors
    Hai Yan leads a team of scientists from Duke and Johns Hopkins universities to identify mutations in a gene that makes cells immortal and appear to play a pivotal role in three of the most common types of brain tumors, as well as cancers of the liver, tongue and urinary tract.
  • Duke Leads World's Largest HIV Vaccine Trial

    Duke Leads World's Largest HIV Vaccine Trial
    Barton Haynes, MD, leads the world’s largest HIV vaccine trial, which provides important clues about immune system responses that could play a role in protecting people from HIV infection. Photo Credit: Duke University School of Medicine
  • Duke Cancer Center Opens

    Duke Cancer Center Opens
  • Mary Duke Biddle Trent Semans Center Opens

    Mary Duke Biddle Trent Semans Center Opens
    Mary Duke Biddle Trent Semans Center for Health Education opens. The new six-story, 104,000-square-foot health education building opened to students in 2012, featuring a floor dedicated to simulation laboratories that can transform from mock clinical exam rooms to surgery suites and emergency rooms.
  • Duke's Robert Lefkowitz, MD, Awarded Nobel Prize in Chemistry

    Duke's Robert Lefkowitz, MD, Awarded Nobel Prize in Chemistry
    On Wednesday, October 10, 2012, The Royal Swedish Academy of Sciences announced that Robert Lefkowitz, MD, a Howard Hughes Medical Institute (HHMI) investigator at Duke University, and Brian K. Kobilka of Stanford University were the recipients of the 2012 Nobel Prize in Chemistry for studies of G-protein-coupled receptors.
  • Bioengineered Blood Vessel Developed

    Bioengineered Blood Vessel Developed
    Jeffrey Lawson, MD, PhD (pictured), and Laura Niklason, MD, PhD, of Yale University develop a bioengineered blood vessel, which Lawson grafts into an artery in a patient’s arm, the first in-human procedure of its kind in the U.S. Photo Credit: Duke University School of Medicine
  • Breakthrough in Treatment of Neurological Disorders

    David Goldstein, PhD, identifies two new genes and implicates 25 distinct mutations in serious forms of epilepsy, suggesting a new direction for developing tailored treatments of neurological disorders.
  • Duke Heart Transplant Program Celebrates 25th Anniversary

    Duke Heart Transplant Program Celebrates 25th Anniversary
    Duke celebrates the 25th anniversary of the creation of its heart transplant program. More than 1,000 patients have received new hearts through the program. Photo Credit: Duke University Medical Center Archives
  • Funding Supports Umbilical Cord Blood Cell Research

    Duke researchers receive $15 million to support an innovative research program that explores the use of umbilical cord blood cells to treat autism, stroke, cerebral palsy and related brain disorders.
  • A. Eugene Washington, MD, MPH, MSc, Named Chancellor for Health Affairs and President and and CEO of DUHS

    A. Eugene Washington, MD, MPH, MSc, Named Chancellor for Health Affairs and President and and CEO of DUHS
    A. Eugene Washington, MD, MPH, MSc, is Chancellor for Health Affairs and President and CEO of the Duke University Health System.
  • First Hand Transplant in N.C.

    First Hand Transplant in N.C.
    A Duke team, led by Linda Cendales, MD (pictured), performs the first hand transplant in N.C., attaching the limb to a 54-year-old patient from Laredo, Texas, whose hand was severed in a childhood accident. Photo Credit: Duke University School of Medicine
  • Duke's Paul Modrich, PhD, Awarded Nobel Prize for Chemistry

    Duke's Paul Modrich, PhD, Awarded Nobel Prize for Chemistry
    Paul Modrich, James B. Duke Professor of Biochemistry, was awarded the 2015 Nobel Prize for Chemistry along with Tomas Lindahl of the Francis Crick Institute and Clare Hall Laboratory in the UK, and Aziz Sancar of University of North Carolina, Chapel Hill, for mechanistic studies of DNA repair.
  • Mary Klotman, MD, Named Dean of School of Medicine and Vice Chancellor for Health Affairs

    Mary Klotman, MD, Named Dean of School of Medicine and Vice Chancellor for Health Affairs
    A nationally recognized leader in academic medicine, Mary E. Klotman, MD, was named dean of the Duke University School of Medicine and vice chancellor for health affairs at Duke University in January 2017, and assumed her new role on July 1, 2017. Photo Credit: Duke University School of Medicine
  • Duke Cancer Institute Therapy Promising for Gioblastoma Long-Term Survival

    Duke Cancer Institute Therapy Promising for Gioblastoma Long-Term Survival
    A genetically modified poliovirus therapy developed at Duke Cancer Institute shows significantly improved long-term survival for patients with recurrent glioblastoma, with a three-year survival rate of 21 percent in a phase 1 clinical trial. Photo: Dr. Alan Friedman performs a Gioblastoma biopsy. Credit: Duke University School of Medicine.
  • Gut Cells Pathways Discovery Made

    Gut Cells Pathways Discovery Made
    Duke researchers, led by Diego Bohórquez, PhD (pictured), discover a new set of pathways that allow gut cells to rapidly communicate with the brain. Photo Credit: Duke University School of Medicine
  • Breakthrough in Peanut Allergies

    Breakthrough in Peanut Allergies
    In a study using mice bred to have peanut allergies, Duke researchers were able to reprogram the animals' immune systems using a nanoparticle delivery of molecules to the lymph nodes that switched off the life-threatening reactions to peanut exposures. Photo Credit: Duke Health News Office
  • Breakthrough in Brain Tumor Research

    A Duke team, led by Peter E. Fecci, MD, PhD, finds missing immune cells that could fight lethal brain tumors. The missing T-Cells in glioblastoma patients were found in abundance in bone marrow.
  • Duke Performs First HOPE Act HIV+ Live Kidney Transplant in N.C. and Region

    Duke Performs First HOPE Act HIV+ Live Kidney Transplant in N.C. and Region
    A donor’s altruism leads to the nation’s second HIV-positive live kidney transplant (pictured). Photo Credit: Duke Health
  • Duke Receives Award to Develop Vaccine to Replace Flu Shot

    Duke Human Vaccine Institute received three research contracts from the National Institute of Allergy and Infectious Diseases (NIAID), with an initial award of approximately $29.6 million in first-year funding to develop a longer-lasting, more broadly protective vaccine to replace the seasonal flu shot.
  • $129M Grant Awarded for HIV Vaccine Research

    Duke Human Vaccine Institute Awarded $129 Million Grant in Ongoing Quest for HIV Vaccine
  • Duke Joins First Study for COVID-19 Therapy

    Duke Joins First Study for COVID-19 Therapy
    Duke University Hospital joined the first national study to test a potential therapy—remdesivir—for COVID-19, giving hospitalized adult patients with significant symptoms an option to participate. Cameron Wolfe, MD, is PI, and Chip Walter, MD, is co-PI. Photo Credit: Duke University School of Medicine
  • DCRI Leads National Study of Healthcare Workers During COVID-19

    DCRI Leads National Study of Healthcare Workers During COVID-19
    The Duke Clinical Research Institute (DCRI)-led Healthcare Worker Exposure Response & Outcomes (HERO) Registry launched in April 2020, inviting U.S. healthcare workers to share clinical and life experiences in order to understand the perspectives and problems faced by those on the COVID-19 pandemic front lines.
  • DHVI To Test Monoclonal Antibody Preventative for COVID-19

    The Duke Human Vaccine Institute Pandemic Prevention Program (DHVI-P3) received an additional $7.6 million in federal funding to manufacture and test in humans a neutralizing monoclonal antibody for the prevention of COVID-19. The funding, from the U.S. Department of Defense, Defense Advanced Research Project Agency (DARPA), enables the Duke team to move forward with a Phase 1 study of highly potent antibodies isolated from COVID-19 patients who have recovered from the illness.
  • Duke’s Aggressive COVID Testing, Surveillance Minimized Infections

    An aggressive COVID-19 surveillance and testing effort at Duke University was highly effective in minimizing the spread of the disease among students on campus, according to a case study appearing in a CDC Morbidity and Mortality Weekly Report Nov. 17, 2020.
  • Duke Health Employees Begin Receiving COVID-19 Vaccine

    Duke Health Employees Begin Receiving COVID-19 Vaccine
    Twelve Duke Health employees are the first to receive the Pfizer/BioNTech COVID-19 vaccine on Dec. 14, 2020.